Elevance Health, Inc.
ELV
$376.63
$13.893.83%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.76B | 547.00M | 1.19B | 1.74B | 2.18B |
| Total Depreciation and Amortization | 354.00M | -397.00M | 387.00M | 380.00M | 373.00M |
| Total Amortization of Deferred Charges | -- | 803.00M | -- | -- | -- |
| Total Other Non-Cash Items | -446.00M | -345.00M | 309.00M | 149.00M | 246.00M |
| Change in Net Operating Assets | 2.66B | -524.00M | -750.00M | -218.00M | -1.79B |
| Cash from Operations | 4.33B | 84.00M | 1.14B | 2.05B | 1.02B |
| Capital Expenditure | -235.00M | -293.00M | -360.00M | -267.00M | -196.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.00M | 33.00M | 1.00M | 50.00M | 4.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.41B | 724.00M | -865.00M | -470.00M | 295.00M |
| Cash from Investing | -1.64B | 464.00M | -1.22B | -687.00M | 103.00M |
| Total Debt Issued | 1.04B | 1.56B | 3.54B | 261.00M | 836.00M |
| Total Debt Repaid | -2.05B | -542.00M | -2.07B | 110.00M | -1.37B |
| Issuance of Common Stock | 37.00M | 58.00M | 0.00 | -- | 23.00M |
| Repurchase of Common Stock | -1.16B | -472.00M | -867.00M | -297.00M | -1.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -376.00M | -377.00M | -381.00M | -385.00M | -386.00M |
| Other Financing Activities | -3.00M | 12.00M | 21.00M | 3.00M | -14.00M |
| Cash from Financing | -2.52B | 236.00M | 243.00M | -308.00M | -1.91B |
| Foreign Exchange rate Adjustments | -9.00M | -6.00M | -1.00M | 1.00M | 1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.00M | 778.00M | 153.00M | 1.06B | -788.00M |